Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR

van Stekelenborg, John, Ellenius, Johan, Maskell, Simon ORCID: 0000-0003-1917-2913, Bergvall, Tomas, Caster, Ola, Dasgupta, Nabarun, Dietrich, Juergen, Gama, Sara, Lewis, David, Newbould, Victoria
et al (show 8 more authors) (2019) Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR. DRUG SAFETY, 42 (12). pp. 1393-1407.

Access the full-text of this item by clicking on the Open Access link.


Over a period of 3 years, the European Union's Innovative Medicines Initiative WEB-RADR project has explored the value of social media (i.e., information exchanged through the internet, typically via online social networks) for identifying adverse events as well as for safety signal detection. Many patients and clinicians have taken to social media to discuss their positive and negative experiences of medications, creating a source of publicly available information that has the potential to provide insights into medicinal product safety concerns. The WEB-RADR project has developed a collaborative English language workspace for visualising and analysing social media data for a number of medicinal products. Further, novel text and data mining methods for social media analysis have been developed and evaluated. From this original research, several recommendations are presented with supporting rationale and consideration of the limitations. Recommendations for further research that extend beyond the scope of the current project are also presented.

Item Type: Article
Uncontrolled Keywords: Humans, Adverse Drug Reaction Reporting Systems, Algorithms, European Union, Internet, Pharmacovigilance, Social Media, Drug-Related Side Effects and Adverse Reactions
Depositing User: Symplectic Admin
Date Deposited: 03 Dec 2019 11:29
Last Modified: 19 Jan 2023 00:17
DOI: 10.1007/s40264-019-00858-7
Open Access URL:
Related URLs: